<DOC>
	<DOCNO>NCT02926300</DOCNO>
	<brief_summary>The purpose clinical trial evaluate long-term safety efficacy patient history FURESTEM-CD injection least .</brief_summary>
	<brief_title>Long-term Safety Efficacy FURESTEM-CD Inj . Patients With Moderately Active Crohn 's Disease ( CD )</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>patient history FURESTEMCD Inj . injection least . patient understand voluntarily sign informed consent form . condition PI judge would make subject unsuitable study participation .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>crohn 's disease</keyword>
	<keyword>stem cell therapy</keyword>
	<keyword>inflammatory bowel disease</keyword>
	<keyword>hUCB-MSC</keyword>
	<keyword>UCB-MSC</keyword>
	<keyword>Umbilical cord Blood</keyword>
</DOC>